Following a successful funding round, Deepbridge have seen a rise of 40% in subscriptions for the Life Sciences fund in comparison to last year.
Dr Savvas Neophytou, Partner and Head of Life Sciences at Deepbridge, commented:
“The past twelve months has shone a spotlight on the world-leading innovation in the UK life sciences sector like never before, and we have understandably seen significant growth in investor interest as a result.”
Read more in IFA Magazine, here.
By following this link, you will leave the Deepbridge website. Deepbridge takes no responsibility for content on external websites.
- March 2025 (1)
- February 2025 (1)
- January 2025 (1)
- December 2024 (1)
- November 2024 (1)
- October 2024 (4)
- September 2024 (4)
- August 2024 (4)
- July 2024 (1)
- June 2024 (3)
- May 2024 (2)
- April 2024 (2)
- March 2024 (3)
- February 2024 (8)
- January 2024 (7)
- December 2023 (1)
- November 2023 (7)
- October 2023 (6)